Wijnhoven Bas P L, Lally Carolyn J, Kelly John J, Myers Jennifer C, Watson David I
Flinders University Department of Surgery, Flinders Medical Centre, Bedford Park, South Australia, 5042, Australia.
J Gastrointest Surg. 2008 Mar;12(3):510-7. doi: 10.1007/s11605-007-0443-1. Epub 2007 Dec 11.
It is claimed that a substantial number of patients who undergo antireflux surgery use antireflux medication postoperatively. This study was aimed to determine the prevalence and underlying reasons for antireflux medication usage in patients after surgery.
A questionnaire on the usage of antireflux medication was sent to 1,008 patients identified from a prospective database of patients who had undergone a laparoscopic antireflux procedure.
A total of 844 patients (84%) returned the questionnaire. Mean follow-up was 5.9 years after surgery. A single or combination of medications was being taken by 312 patients (37%): 82% proton pump inhibitors, 9% H2-blockers and 34% antacids. Fifty-two patients (17%) had never stopped taking medication, whereas 260 patients (83%) restarted medication at a mean of 2.5 years after surgery. Return of the same (31%) or different (49%) symptoms were the commonest reasons for taking medication, whereas 20% were asymptomatic or had other reasons for medication use. Postoperative 24-hour pH studies were abnormal in 16/61 patients (26%) on medication and in 5/78 patients (6%) not taking medication.
Antireflux medication is frequently taken by many patients for various symptoms after antireflux surgery. Symptomatic patients should be properly investigated before antireflux medications are prescribed.
据称,大量接受抗反流手术的患者术后仍使用抗反流药物。本研究旨在确定手术后患者使用抗反流药物的患病率及潜在原因。
一份关于抗反流药物使用情况的问卷被发送给从接受腹腔镜抗反流手术患者的前瞻性数据库中识别出的1008名患者。
共有844名患者(84%)回复了问卷。术后平均随访时间为5.9年。312名患者(37%)正在服用单一药物或联合用药:82%为质子泵抑制剂,9%为H2受体阻滞剂,34%为抗酸剂。52名患者(17%)从未停止用药,而260名患者(83%)在术后平均2.5年重新开始用药。出现相同(31%)或不同(49%)症状是用药最常见的原因,而20%的患者无症状或有其他用药原因。在用药的61名患者中有16名(26%)术后24小时pH值研究异常,在未用药的78名患者中有5名(6%)异常。
许多患者在抗反流手术后因各种症状频繁服用抗反流药物。有症状的患者在开抗反流药物之前应进行适当的检查。